Jing Liu
机构:Zhejiang Chinese Medical University, Tongji University, University of Science and Technology of China, Central South University, Nanchang University, Anhui University, Yangtze University, Guizhou University, Chinese Academy of Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, State Ethnic Affairs Commission, Hospital of the University of Pennsylvania, Peking Union Medical College Hospital, Hefei Institutes of Physical Science, North Minzu University, Shantou University, Chinese Academy of Engineering, Cancer Hospital of Shantou University Medical College, First Affiliated Hospital of Jiangxi Medical College, Suizhou Central Hospital, Guizhou Minzu University, Zhongzhu Healthcare (China), Cell Technology (China), Precision for Medicine (United States), Lanzhou University Second Hospital, Peking University People's Hospital, National Clinical Research, Shanghai Tenth People's Hospital, Chengdu Fifth People's Hospital, Sinotech Genomics (China), Oil Crops Research Institute, Research Center for Eco-Environmental Sciences, Precision Research (United States), Shenzhen Technology University, Third Xiangya Hospital, University of Chinese Academy of Sciences, Hefei Infectious Disease Hospital, State Key Laboratory of Environmental Chemistry and Ecotoxicology, Anhui Polytechnic University, Lanzhou University
发表论文 361 篇 · 总被引 8630 次 · h-index 44
代表论文
- RNA N4‐acetylcytidine modification and its role in health and diseases (2025 · MedComm · 被引 32)
- Unraveling the signaling pathways of plant cold stress: current insights and future directions (2025 · Frontiers in Plant Science · 被引 20)
- Cell‐free epigenomes enhanced fragmentomics‐based model for early detection of lung cancer (2025 · Clinical and Translational Medicine · 被引 15)
- Integrated multiomics analysis and machine learning refine neutrophil extracellular trap-related molecular subtypes and prognostic models for acute myeloid leukemia (2025 · Frontiers in Immunology · 被引 9)
- Design and supercapacitor applications of nitrogen, sulfur-codoped carbon foam from over-foaming-prone lignin (2025 · Bioresource Technology · 被引 8)
- Randomized trial of anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease in haploidentical transplantation (2025 · Haematologica · 被引 7)